Correlation between the Degree of Glycocalyx Damage and the Incidence of Acute Kidney Injury in Sepsis Patients in the Intensive Care Unit: A Review of Syndecan-1 and sICAM-1

Haizah Nurdin; Syafri Kamsul Arif; A. Husni Tanra; Muh. Ramli Ahmad; Made Wiryana; Muh. Nasrum Massi; Haerani Rasyid; Agussalim Bukhari

doi:10.3889/oamjms.2022.10471

Authors

Haizah Nurdin Department of Anesthesiology, Wahidin Sudirohusodo Hospital and Hasanuddin University, Makassar https://orcid.org/0000-0001-6919-4171
Syafri Kamsul Arif Department of Anesthesiology, Wahidin Sudirohusodo Hospital and Hasanuddin University, Makassar
A. Husni Tanra Department of Anesthesiology, Wahidin Sudirohusodo Hospital and Hasanuddin University, Makassar
Muh. Ramli Ahmad Department of Anesthesiology, Wahidin Sudirohusodo Hospital and Hasanuddin University, Makassar
Made Wiryana Department of Anesthesiology, Udayana University, Bali
Muh. Nasrum Massi Department of Microbiology, Hasanuddin University, Makassar
Haerani Rasyid Department of Internal Medicine, Hasanuddin University, Makassar
Agussalim Bukhari Department of Clinical Nutrition, Faculty of Medicine Hasanuddin University, Makassar

DOI:

https://doi.org/10.3889/oamjms.2022.10471

Keywords:

Syndecan-1, sICAM-1, The severity of glycocalyx damage, Acute kidney injury

Abstract

Abstracts

Objective: This study aims to know the correlation between the degree of glycocalyx damage and the incidence of Acute Renal Injury (AKI) in sepsis patients in the intensive care unit. In this study, a review of Syndecan-1 and sICAM-1 marker represented the severity of glycocalyx damage. Furthermore, the researchers wanted to see whether this marker in the serum of septic patients could predict the occurrence of AKI in the future of septic patients in the ICU.

Design: This study is a prospective cohort nested-case control study, a case-control study conducted in a cohort population.

Setting: This research has been carried out in the ICU, both RSPTN UNHAS and Dr. Wahidin Sudirohusodo Makassar. Syndecan-1 and sICAM-1 examination was carried out in the Hasanuddin University Hospital laboratory.

Patients and participants: The sample was taken from septic patients treated in the ICU of RSPTN UNHAS and Dr. Wahidin Sudirohusodo Makassar admitted in January 2021. The sample selection was carried out consecutively, namely the selection of respondents based on the arrival of patients treated in the ICU until fulfilled.

Measurement and Results: Data analysis in this study used the Mann-Whitney and Unpaired T-test. There was a significant difference in serum syndecan-1 levels between the two groups on day 0 and day 3 of ICU admission and changes from day 0 to day three. However, there was no significant relationship between sICAM-1 level in the two groups on day 0 and day 3 of ICU admission likewise its changes. Changes in syndecan-1 levels between the two groups were significantly different through the unpaired T-test.

Conclusions: In this study, syndecan-1 levels can be used to predict the occurrence of AKI in the future for septic patients, while sICAM-1 is not statistically significant in predicting the occurrence of AKI among septic patients. Syndecan-1 is vital in the glycocalyx damage and helps predict clinical outcomes in patients with AKI.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: The intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380-6. https://doi.org/10.1016/S2213-2600(14)70061-X PMid:24740011

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Baue M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801-10. https://doi.org/10.1001/jama.2016.0287 PMid:26903338

Marx G. Fluid therapy in sepsis with capillary leakage. Eur J Anaesthesiol. 2003;20(6):429-42. https://doi.org/10.1017/S0265021503000681 PMid:12803259

Ince C, Mayeux PR, Nguyen T, Gomez H, Kellum JA, Hernandez G, et al. The endotelium sepsis. Shock. 2016;45(3):259-70. https://doi.org/10.1097/SHK.0000000000000473 PMid:26871664

Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121-67. https://doi.org/10.1146/annurev.bioeng.9.060906.151959 PMid:17373886

Inkinen N, Pettilä V, Lakkisto P, Kuitunen A, Jukarainen S, Bendel S, et al. Association of endothelial and glycocalyx injury biomarkers with fluid administration, development of acute kidney injury, and 90-day mortality: Data from the FINNAKI observational study. Ann Intensive Care. 2019;9(1):103. https://doi.org/10.1186/s13613-019-0575-y PMid:31512003

Van Teeffelen JW, Brands J, Stroes ES, Vink H. Endothelial glycocalyx: Sweet shield of blood vessels. Trends Cardiovasc Med. 2007;17(3):101-5. https://doi.org/10.1016/j.tcm.2007.02.002 PMid:17418372

Kolářová H, Ambruzová B, Šindlerová LŠ, Klinke A, Kubala L. Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediators Inflamm. 2014;2014:694312. https://doi.org/10.1155/2014/694312 PMid:24803742

Chelazzi C, Villa G, Mancinelli P, De Gaudio AR, Adembri C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care. 2015;19(1):26. https://doi.org/10.1186/s13054-015-0741-z PMid:25887223

Martin L, Koczera P, Zechendorf E, Schuerholz T. The endothelial glycocalyx: New diagnostic and therapeutic approaches in sepsis. Biomed Res Int. 2016;2016:3758278. https://doi.org/10.1155/2016/3758278 PMid:27699168

Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411-23. https://doi.org/10.1007/s00134-015-3934-7 PMid:26162677

Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, et al. Acute kidney injury in septic shock: Clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med. 2009;35(5):871-81. https://doi.org/10.1007/s00134-008-1367-2 PMid:19066848

Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol. 2009;22(2):155-62. https://doi.org/10.1097/ACO.0b013e328328d1b6 PMid:19307890

De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL. Microcirculatory alterations: Potential mechanisms and implications for therapy. Ann Intensive Care. 2011;1(1):27. https://doi.org/10.1186/2110-5820-1-27 PMid:21906380

Zafrani L, Payen D, Azoulay E, Ince C. The microcirculation of the septic kidney. Semin Nephrol. 2015;35(1):75-84. https://doi.org/10.1016/j.semnephrol.2015.01.008 PMid:25795501

Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, et al. Sepsis as a cause and consequence of acute kidney injury: Program to improve care in acute renal disease. Intensive Care Med. 2011;37(2):241-8. https://doi.org/10.1007/s00134-010-2089-9 PMid:21152901

Sang L, Chen S, Zheng X, Guan W, Zhang Z, Liang W, et al. The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: A retrospective study. BMC Pulm Med. 2020;20(1):290. https://doi.org/10.1186/s12890-020-01305-5 PMid:33167955

Peres LA, Wandeur V, Matsuo T. Predictors of acute kidney injury and mortality in an intensive care unit. J Bras Nefrol. 2015;37(1):38-46. https://doi.org/10.5935/0101-2800.20150007 PMid:25923749

Ju S, Lee TW, Yoo JW, Lee SJ, Cho YJ, Jeong YY, et al. Body mass index as a predictor of acute kidney injury in critically Ill patients: A retrospective single-center study. Tuberc Respir Dis (Seoul). 2018;81(4):311-8. https://doi.org/10.4046/trd.2017.0081 PMid:29926539

Dekker MJ, Sande FM, Van Den Berghe F, Leunissen KM, Kooman JP. Fluid overload and inflammation axis. Blood Purif. 2018;45(1-3):159-65. https://doi.org/10.1159/000485153 PMid:29478061

Wang H, Kang X, Shi Y, Bai ZH, Lv JH, Sun JL, et al. SOFA score is superior to APACHE-II score in predicting the prognosis of critically ill patients with acute kidney injury undergoing continuous renal replacement therapy. Ren Fail. 2020;42(1):638-45. https://doi.org/10.1080/0886022X.2020.1788581 PMid:32660294

Ananda D, Ray S, Mohan LS, Bhargava S. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients. Clin Biochem. 2016;49(10-11):768-76. https://doi.org/10.1016/j.clinbiochem.2016.02.014 PMid:26953518

Cavalcante CT, Branco KM, Júnior VC, Meneses GC, Neves FM, De Souza NM, et al. Syndecan-1 improves severe acute kidney injury prediction after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2016;152(1):178-86. https://doi.org/10.1016/j.jtcvs.2016.03.079 PMid:27343912

Paulus P, Jennewein C, Zacharowski K. Biomarkers of endothelial dysfunction: Can they help us deciphering systemic inflammation and sepsis? Biomarkers. 2011;16(Suppl 1):S11-21 https://doi.org/10.3109/1354750X.2011.587893 PMid:21707440

Dehne MG, Sablotzki A, Mühling J, Hartmann B, Röhrig R, Meister M. Evaluation of sE-Selectin and sICAM-1 as parameters for renal function. Ren Fail. 2008;30(7):675-84. https://doi.org/10.1080/08860220802212353 PMid:18704815

De Pablo R, Monserrat J, Reyes E, Díaz D, Rodríguez-Zapata M, Hera AD, et al. Circulating sICAM-1 and sE-Selectin as biomarker of infection and prognosis in patients with systemic inflammatory response syndrome. Eur J Intern Med. 2013;24(2):132-8. https://doi.org/10.1016/j.ejim.2012.10.009 PMid:23352000

Sullivan RC, Rockstrom MD, Schmidt EP, Hippensteel JA. Endothelial glycocalyx degradation during sepsis: Causes and consequences. Matrix Biol Plus. 2021;12:100094. https://doi.org/10.1016/j.mbplus.2021.100094 PMid:34917925

Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: Relation to mortality and the antibacterial actions of plasma. Shock. 2008;30(6):623-7. https://doi.org/10.1097/SHK.0b013e3181777da3 PMid:18497712